
Ounce Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.6/10
Best for: people who want to lock in a posted all-in GLP-1 price with labs included before the service opens
Ounce scores highest on the strength of its clinical program — drug options and dosing support.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Not disclosed
Lab work
Included
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Ounce is a new telehealth weight-loss brand that has not opened yet: for now you take a two-minute eligibility check and hold a spot with a refundable $25 deposit. It plans to offer compounded semaglutide and tirzepatide injections and a semaglutide dissolving tablet. Month-to-month prices are $249 for semaglutide, $279 for the tablet and $339 for tirzepatide, with clinician visits and baseline labs included.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Ounce
Sprout Health
Best for: LegitScript-certified compounded GLP-1 via named pharmacies
Editorial score · methodology
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
MEDVi
Best for: switching between compounded and brand-name GLP-1 through one provider
Editorial score · methodology
Ounce at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $249/mo
- What's included
- Medication · Consult · Labs
- FDA status
- No FDA warning letter on record
How we scored Ounce
Each dimension is scored algorithmically from Ounce’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
5.8/10At $249/mo, Ounce runs about 47% above the $169 median for GLP-1 providers.
Effectiveness25%
7.8/10Ounce offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
7.0/10Online intake and platform experience — consult included in the price; 6 platform features disclosed.
Trust & Safety15%
6.9/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
5.7/10Ounce's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
5.5/10Ounce provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Ounce review
Last checked October 2026- Confirmed current pricing across 3 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $249–$339/mo across 3 dose/plan tiers — checked October 2026
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Ounce
We walked Ounce’s public signup flow in October 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Every Check eligibility button opens the same five-step check, which says no account is needed yet
- 2Pick a main goal, then an age band; under 18 or over 74 ends the check
- 3Enter height and weight, and the screen shows your BMI as you type
- 4Answer a safety screen covering pregnancy, thyroid cancer history, pancreatitis and type 1 diabetes
- 5Choose your state, then see a likely-eligible result with your plan price
- 6The result screen asks for email and ZIP code and a refundable $25 deposit to reserve a spot (walk stopped here)
- Ounce is not open yet; the result screen says it will email you once it opens in your state
- The price on the result screen matches the home page, with semaglutide injections at $249 billed monthly
- The $25 deposit is described as fully refundable and counts toward your first month
- The check asks no detailed medical history; a clinician reviews your answers only after launch
- Baseline labs at Quest or Labcorp are listed as included and can follow after you start
- The site promises a care team available 24/7 but lists no Ounce support phone line
- We did not take the medication; nothing here describes a patient outcome
GLP-1 medications Ounce offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Launch price. 12, 24 and 52-week plans cost $657, $1,194 and $2,327 ($219, $199 and $179 per 4-week shipment)
Launch price. 12, 24 and 52-week plans cost $777, $1,434 and $2,717 ($259, $239 and $209 per 4-week shipment)
Launch price. 12, 24 and 52-week plans cost $927, $1,734 and $3,497 ($309, $289 and $269 per 4-week shipment)
Ready to get started?
Plans and promotions change often — check Ounce's current pricing and active discounts before you decide.
What we like
- Every plan price is posted on the home page and again on the result screen before you give any contact details
- The monthly price includes clinician visits, messaging and baseline labs at Quest or Labcorp
- Offers compounded semaglutide and tirzepatide injections plus a semaglutide dissolving tablet for people who avoid needles
- The eligibility check takes about two minutes and needs no account or payment to see your result
- The $25 deposit is fully refundable and counts toward your first month if you start treatment
- The site says you can cancel any time and request a refund for any month whose medication has not been ordered
Watch-outs
- Ounce has not launched yet, so you can only reserve a spot and wait for an email saying it has opened in your state
- Neither the medical practice that would treat you nor the dispensing pharmacy is named anywhere on the site
- Longer plans are priced per month but billed per 4-week shipment, so a 52-week plan bills 13 shipments, not 12
- The home page says review usually happens without a video call, but another page describes a video visit first
- The brand is days old, with no LegitScript record and no independent customer reviews
- Shipping costs are not stated, and the coaching program is an optional extra
Is Ounce worth it?
What Ounce is selling, in one line, is people who want to lock in a posted all-in GLP-1 price with labs included before the service opens. It runs $249/month — a premium versus the rest of the category, so its specific extras need to earn that difference. Its standout is a needle-free oral option, which very few providers offer.
Worth knowing before you sign up: Ounce includes lab testing and lets you cancel anytime.
How much Ounce actually costs
Compounded semaglutide runs $249/month, compounded semaglutide runs $279/month, and compounded tirzepatide runs $339/month.
For context, the typical ongoing price across the GLP-1 providers we track is around $169/month. Ounce's standing rate sits at the premium end of that range, well above the cheapest options in the category.
For a direct comparison, Wellorithm runs semaglutide and tirzepatide from $247/month — worth pricing against Ounce before you commit.
Medications: what Ounce prescribes
Ounce prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. The medication is compounded at a licensed pharmacy rather than sold as a brand pen, which is what keeps the price down. The trade-off is the one every compounded provider shares: compounded drugs aren't FDA-approved as finished products.
Ounce's needle-free oral option is a real draw if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used. Treat it as a convenience option, not a proven equal to the shot.
Who Ounce is best for — and who should skip it
A good fit if you…
- are needle-averse and want a non-injectable option, since the oral route skips the weekly injection most GLP-1 programs require.
Look elsewhere if you…
- want the lowest total cost over 6–12 months — a flat-rate provider like Collective will likely beat the ongoing price.
- specifically want an FDA-approved brand-name pen instead of a compounded formulation — that's not what this provider fills.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
We found no FDA warning letter on file for it, though a clean record isn't the same as an endorsement — read the rest of this review for the full picture. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
Ounce costs more than the budget end of the market, so it makes the most sense if its specific extras — the oral option especially matter to you. If they don't, you can likely get the same medication for less elsewhere. If you're comparison-shopping, Direct Meds is one of the closest alternatives we track — worth a look before deciding.
The Bottom Line
Ounce scores highest on the strength of its clinical program — drug options and dosing support.
Ready to start with Ounce?
Starting at $249/month. See current pricing and start your free consultation.
Ounce might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
- If the lowest possible monthly price is your top priority, consider Collective (from $59/mo).
- If you want built-in coaching and behavior-change support, consider MEDVi.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Ounce review:
Sources & methodology — as of October 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Ounce's current pricing
Plans start at $249/month. Start your free consultation to check eligibility and today's price.